Drugs News and Research

RSS

NABP report highlights significance of international collaboration in fight against illegal online drug sellers

Today, the National Association of Boards of Pharmacy issued a report discussing the importance of international collaboration in the fight against illegal online drug sellers. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: October 2015, there is widespread agreement among multiple countries that Internet sales of medicinal products pose a health risk to their citizens.

31 Oct 2015

FDA initiates NTSO actions for retailers who violated certain restrictions on sale of tobacco products

This week the U.S. Food and Drug Administration filed complaints initiating the first-ever No-Tobacco-Sale Order (NTSO) actions for a group of retailers who have repeatedly violated certain restrictions on the sale and distribution of tobacco products, including sales to minors. Under the law, the FDA may pursue an NTSO against retailers that have a total of five or more repeated violations of those restrictions during compliance inspections within 36 months.

31 Oct 2015

University of Kansas professor recognized with MERIT Award

Emily Scott, professor of medicinal chemistry at the University of Kansas, has been recognized with a MERIT Award from the National Institutes of Health's National Institute of General Medical Sciences. It's a rare and important recognition -- researchers can receive them only once in a career.

30 Oct 2015

Q BioMed signs definitive license agreement with Mannin Research

Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.

30 Oct 2015

Physicians leave severe acne patients on ineffective antibiotics for too long before prescribing more potent drug

A medical records analysis by researchers at NYU Langone Medical Center concludes that physicians who treat severe acne leave too many patients on ineffective antibiotics for far too long before prescribing more potent needed therapy with the medication isotretinoin, sometimes known by its former brand name Accutane.

30 Oct 2015

Mallinckrodt announces approval of INOmax for cardiovascular surgery in Australia and Japan

Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.

30 Oct 2015

Isis Pharmaceuticals begins ISIS-FXI Rx Phase 2 study in patients with ESRD on hemodialysis

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.

30 Oct 2015

Study reports discovery of new class of DNA repair enzyme

This year's Nobel Prize in chemistry was given to three scientists who each focused on one piece of the DNA repair puzzle. Now a new study, reported online Oct. 28 in the journal Nature, reports the discovery of a new class of DNA repair enzyme.

30 Oct 2015

Study sheds light on mechanism of neuronal activity

Neurons communicate by passing electrical messages, known as action potentials, between each other. Each neuron has a highly specialized structural region, the axon initial segment (AIS), whose primary role is in the generation and sending of these messages.

30 Oct 2015

Antibiotics have no adverse outcome on child's physical development, shows study

The four out of ten women who use antibiotics during pregnancy can breathe easy, as a comprehensive new study shows that the two most often prescribed drugs have no adverse outcome on the child's physical development.

30 Oct 2015

Women with elevated breast cancer risk can benefit from regular physical activity

Regular physical activity could play a role in helping women at high-risk of breast cancer delay the need for drastic preventive measures such as prophylactic mastectomy, according to new research led by the Perelman School of Medicine at the University of Pennsylvania.

30 Oct 2015

Halozyme Therapeutics announces initiation of rivipansel Phase 1 clinical trial

Halozyme Therapeutics, Inc. today announced that the first healthy subject has been dosed in a Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of a subcutaneous formulation of rivipansel, a compound discovered by GlycoMimetics, Inc. and being developed by Pfizer Inc., using Halozyme's ENHANZE formulation.

30 Oct 2015

Researchers identify molecular switch that can convert unhealthy white fat into energy-burning brown fat

A research team led by UC San Francisco scientists has identified a molecular switch capable of converting unhealthy white fat into healthy, energy-burning brown fat in mice. Drugs that flip this switch rapidly reduced obesity and diabetes risk factors in mice fed a high fat diet.

30 Oct 2015

New computer-based modeling may help improve outcomes for babies with neonatal abstinence syndrome

Computer-based modeling is helping to further reduce length of hospital stay and duration of treatment with opioids that are used therapeutically to wean babies born in withdrawal from drugs their mothers have taken. This condition is known as neonatal abstinence syndrome (NAS).

30 Oct 2015

New single-agent phototherapy system may form valuable new tool to combat cancer

Researchers at Oregon State University today announced an important advance in the field of cancer imaging and phototherapy, using a single-agent system that may ultimately change the efficacy of cancer surgery and treatment around the world.

30 Oct 2015

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD.

30 Oct 2015

UNM CCC biostatisticians help scientists conduct research on cancer

In contrast to most people, Ji-Hyun Lee, DrPH, doesn't find statistics difficult or boring. For her, statistics is fulfilling because it's how she helps people fight cancer. "People think biostatistics is purely numbers," Lee says, "but my work helps to improve patients' care." She recalls a visit to a hospital patient as a young statistician working for a cystic fibrosis research team.

29 Oct 2015

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

Gastric cancer, otherwise known as stomach cancer, does not respond well to existing treatments and it is currently the third leading cause of cancer death in the world (after lung and liver cancer). Researchers have discovered that certain drugs, currently used to treat breast, ovarian and pancreatic cancers, could also be used to treat certain gastric cancers with a particular pattern of mutations (genomic molecular fingerprint).

29 Oct 2015

New TSRI study highlights urgent need for new treatments to fight growing cancer metastases

A new study from scientists at The Scripps Research Institute helps explain why cancer metastasis is so hard to stop.

29 Oct 2015

New studies raise important questions about impact of statin therapy on effectiveness of flu vaccines

A new pair of studies suggests that statins, drugs widely used to reduce cholesterol, may have a detrimental effect on the immune response to influenza vaccine and the vaccine's effectiveness at preventing serious illness in older adults. Published in The Journal of Infectious Diseases, the findings, if confirmed by additional research, may have implications for flu vaccine recommendations, guidelines for statin use around the time of vaccination, and future vaccine clinical trials in seniors.

29 Oct 2015

Drugs News and Research

NABP report highlights significance of international collaboration in fight against illegal online drug sellers

FDA initiates NTSO actions for retailers who violated certain restrictions on sale of tobacco products

University of Kansas professor recognized with MERIT Award

Q BioMed signs definitive license agreement with Mannin Research

Physicians leave severe acne patients on ineffective antibiotics for too long before prescribing more potent drug

Mallinckrodt announces approval of INOmax for cardiovascular surgery in Australia and Japan

Isis Pharmaceuticals begins ISIS-FXI Rx Phase 2 study in patients with ESRD on hemodialysis

Study reports discovery of new class of DNA repair enzyme

Study sheds light on mechanism of neuronal activity

Antibiotics have no adverse outcome on child's physical development, shows study

Women with elevated breast cancer risk can benefit from regular physical activity

Halozyme Therapeutics announces initiation of rivipansel Phase 1 clinical trial

Researchers identify molecular switch that can convert unhealthy white fat into energy-burning brown fat

New computer-based modeling may help improve outcomes for babies with neonatal abstinence syndrome

New single-agent phototherapy system may form valuable new tool to combat cancer

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

UNM CCC biostatisticians help scientists conduct research on cancer

Certain drugs could be used to treat gastric cancers with particular pattern of mutations

New TSRI study highlights urgent need for new treatments to fight growing cancer metastases

New studies raise important questions about impact of statin therapy on effectiveness of flu vaccines

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News